BioWorld MedTech

Nov. 3, 2011

View Archived Issues

Mela Sciences secures PMA for MelaFind after lengthy delays

Mela Sciences (Irvington, New York) reported that it has received a PMA for its MelaFind skin cancer detection device, after intense discussion with the FDA regarding the device throughout the past few years. Read More

VitroStealth shows potential as a coating for biosensors

Read More

International report: CoreValve system used for first time in Japanese clinical trial

Read More

Washington roundup: CMS announces 27% pay cut for Part B doc fees in FY '12

Read More

Financings roundup: Echo says warrant deal offers financial flexibility

Read More

Patent watch: Biomoda files application for CyPath refinement tool

Read More

Late-Breaking FDA valve stent approvals: Edwards gets FDA approval for Sapien transcather valve

Read More

FDA approves TriVascular's 20-mm Ovation stent system

Read More

NASS Notebook: Orthofix launches Collage bone graft substitute at NASS

Read More

Court report: MRI Associates awarded $52M in damages in case

Read More

HIT roundup: Trend renews membership with MDISS consortium

Read More

Agreements/contracts: Welch Allyn to provide EHR services to organizations

Read More

Deals roundup: Salmat's management buyout of VeCommerce is complete

Read More

Product Briefs

Read More

People in the News

Read More

MDD's Ortho Extra

Read More